OUR STORY
OUR DIFFERENTIATOR

Novel Looking Glass
Innovative Process Technologies
The biopharmaceutical industry represents a $200 billion market globally. Though the promise of recombinant biologics is great, with the global market expected to continue to expand rapidly, biopharmaceutical manufacturing processes are not evolving in step. In fact, biopharmaceutical downstream processing has remained unchanged for decades, largely due to the need for speed to market and for ensuring regulatory compliance. That said, it is evident in the field that there is great and urgent necessity to innovate downstream processing technologies to support the evolving demands of this industry. For example, the emergence of biosimilars necessitates reduction in biopharmaceutical cost. This cost reduction has to be derived from changes to the existing manufacturing processes that enable increased yield, higher purity, higher throughput, lower capital equipment expenditure, and lower operational expenditure.
Mobius Biomedical is focused on creating innovative, process technology solutions to meet the demands of the rapidly expanding and evolving biopharmaceutical industry.